Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - TOTAL CURRENT ASSETS
Total Current Assets KALV - KalVista Pharmaceuticals, Inc.
226 M
LAST VALUE
7.96%
2 YEAR CAGR
14.33%
5 YEAR CAGR
36.69%
10 YEAR CAGR